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DATABASES FOR CLINICAL RESEARCH
The growing availability of digital health data offers many 
opportunities for clinical research. Studies drawing on elec-
tronic data are often efficient, although the usefulness and 
validity of the data depend on the research question. We 
briefly review types of epidemiologic study designs common-
ly used with patient databases and then describe the types of 
electronic databases available, outline considerations for the 
ad hoc design of new databases, and discuss potential limita-
tions to consider when performing database research.
WHAT IS THE RESEARCH QUESTION? 
Epidemiologic questions are often framed around an expo-
sure and an outcome used to answer a predefined question. 
The exposure can be an environmental exposure, medica-
tion, risk factor, or disease state. For example, does isotreti-
noin (exposure) cause irritable bowel disease (outcome)? Or, 
is severe psoriasis (exposure) associated with an increased 
risk of myocardial infarction (outcome)? Outcomes may refer 
to the onset of a disease (incidence), presence of a disease 
(prevalence), or severity or duration of a disease or symptom. 
The research question and nature of the exposure and out-
come variables should guide the choice of epidemiologic 
study design. 
STUDY DESIGNS 
Epidemiologic study designs can be broadly categorized into 
descriptive and analytical studies (Figure 1). Descriptive stud-
ies, such as case reports and case series, tend to be hypothesis 
generating, and they ask questions about what, where, who, 
and when. Alternatively, analytical studies tend to test hypoth-
eses and answer questions about why and how. They include 
both experimental studies (i.e., clinical trials) and observation-
al studies (cross-sectional, cohort, and case–control designs) 
(Vandenbroucke et al., 2007). Cross-sectional studies assess all 
individuals in a sample at the same time point; the downside is 
that they can’t ascertain the temporality of events and therefore 
can’t be used to draw conclusions about causation. Cohort and 
case–control designs follow individuals over time to ascertain 
the relationship between an exposure and an outcome and dif-
fer in terms of whether the population is selected based on the 
exposure (cohort study) or the outcome (case–control study). 
Study design selection should be guided by the suitability of the 
design for the research question at hand and by feasibility con-
straints. For a more complete description of epidemiologic study 
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Figure 1.   Common epidemiologic study designs. RCT, randomized 
controlled trial.
designs, we recommend an introductory textbook (Gordis, 
2013). Electronic databases are most commonly used for obser-
vational studies, but they can also be used for experimental 
studies (e.g., randomizing an intervention for patients within an 
electronic medical record (EMR)) or descriptive studies (search-
ing an EMR for a case series). 
TYPES OF ELECTRONIC DATABASES 
Electronic databases can be categorized by the source of the 
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EMR Data. EMR data are essentially paperless, digital ver-
sions of patient charts generated for the purposes of clini-
cal care. The number of office-based practices and hospitals 
using EMR systems is increasing, yet there is a lack of stan-
dardization and interoperability. Like claims data, EMR data 
are best suited to study outcomes that are easily captured by 
diagnostic codes, yet they may offer the possibility of more 
detailed data via manual review of physician notes or natu-
ral language processing systems. They are also likely to lack 
routinely collected social and behavioral variables, although 
efforts are underway to improve collection of these types of 
data (Adler and Stead, 2015). Some EMRs may be represen-
tative of the general population and capture all of a patient’s 
health-care interactions, such as the Clinical Research 
Practice Datalink or the Health Improvement Network, both 
large UK general-practice research databases. Others may 
include only inpatient or specialty patient care.
Ad hoc data
Ad hoc data are generally designed for a particular study, 
and they often take the form of a prospective cohort study 
in which patients are selected for inclusion on the basis of 
a particular diagnosis or exposure. For this reason, they are 
often disease specific and may lack a control group.
Hybrid data
Large prospective cohort studies such as the Framingham 
Heart Study and the Nurses’ Health Study may be consid-
ered hybrids between repurposed and ad hoc data because 
data (Table 1). One major distinction is whether the data are 
repurposed (that is, originally generated for purposes other 
than clinical research) or the result of an ad hoc design spe-
cific to an individual study. Data that can be used for clini-
cal studies but that were originally designed for a different 
research question fall somewhere in between and are referred 
to as “hybrid data.” 
Repurposed data
Repurposed data include both administrative claims data, 
which are generated for billing purposes, and EMR data, 
which are generated for the purposes of patient care. 
Additionally, repurposed data include public health reg-
istry data such as cancer registries like the Surveillance, 
Epidemiology, and End Results (SEER) program in the United 
States and death registries that may be linked to claims or 
EMRs. 
Administrative claims data. Administrative claims data 
include inpatient and outpatient medical record codes, and 
these may be linked with pharmacy prescriptions and labora-
tory values. They often contain limited demographic and risk 
factor information, and they may have variable follow-up, 
especially in the United States, because patients frequently 
change insurers. Claims have been widely used in health ser-
vices research and pharmacoepidemiology, and they are best 
suited to study outcomes that are easily captured by diagnos-
tic codes such as procedures or acute events. 
Table 2.   Considerations for the design of a patient database
Consistent	data	
collection
Provide	clear,	operational	definitions	of	data	elements.	Create	and	distribute	standard	instructions	to	data	collections.	Use	
standardized	data	element	definitions	and/or	data	dictionaries	whenever	possible—review	the	literature	to	identify	existing,	
widely	used	definitions	before	drafting	new	definitions
Systematic	patient	
enrollment	and	
follow-up
Enroll	patients	systematically	and	follow	them	in	as	unbiased	a	manner	as	possible,	using	similar	procedures	at	all	participating	
sites.	Describe	how	patients	and	providers	were	recruited	into	the	study.	Monitor	and	minimize	loss	to	follow-up.	Develop	a	
patient	retention	plan	that	documents	when	a	patient	will	be	considered	lost	to	follow-up	and	what	actions	will	be	taken	to	
minimize	such	loss
Data	quality	assurance Create	structured	training	tools	for	data	abstractors.	Perform	data	quality	checks	for	ranges	and	logical	consistency	for	key	
exposure	and	outcome	variables
Data	safety	and	
security
Provide	transparency	by	describing	data	use	agreements,	informed	consent,	data	security,	and	approaches	to	protecting	
security	including	risk	of	identification	of	patients
Adapted from PCORI (2013).
Table 1.   Categories of electronic databases 
Category Examples (with selected dermatology-specific references)
Repurposed data  
				Claims	data 	
									Government	insurers US	Medicare,	US	Medicaid,	national	health	insurers	(Huang	et al.,	2012)	
									Commercial	insurers United	HealthCare,	Pharmetrics	(Arellano	et al.,	2007),	Humana,	Aetna
				Electronic	medical	record	data UK	general	practice	research	databases	(Gelfand	et al.,	2009;	Langan	et al.,	2012);	institution-specific	databases	
(e.g.,	Kaiser	Permanente,	Veterans	Affairs	Computerized	Patient	Record	System)	
				Registry	data Surveillance,	Epidemiology,	and	End	Results	(Linos	et al.,	2009);	Swedish	Family	Cancer	Database	(Chen	et al.,	2014)
Ad	hoc	data Pediatric	Eczema	Elective	Registry	(Mockenhaupt	et al.,	2008);	EuroSCAR	(Mockenhaupt	et al.,	2008)
Hybrid	data
Nurses’	Health	Study,	National	Health	Interview	Survey,	Veterans	Affairs	Million	Veteran	Program,	HMO	Research	
Network,	PatientsLikeMe
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they represent large amounts of data that have been used 
to test many hypotheses beyond the one they were origi-
nally designed to study. Similarly, national survey data are 
available that typically offer cross-sectional snapshots of 
patient-reported risk factors and health outcomes such as 
the National Health Nutrition and Examination Survey 
(NHANES) or the National Health Interview Survey. Finally, 
a newer type of electronic health data is becoming available 
via crowdsourcing (Ranard et al., 2014; Wicks et al., 2010). 
These data are particularly useful for rare exposures or out-
comes, but they are prone to selection bias and information 
bias because they rely on patient self-reporting.
DESIGN OF A NEW AD HOC PATIENT DATABASE
The Patient-Centered Outcomes Research Initiative has out-
lined a number of general considerations for the design of a 
patient database or registry (Table 2) (PCORI, 2013). Another 
important consideration concerns patient selection. If pos-
sible, researchers should enroll all individuals who meet the 
case definition (or a random selection of these individuals) to 
ensure the external validity or generalizability of the results. 
They may also consider using incident cases to help differ-
entiate between exposures prior to and after the onset of dis-
ease. Finally, researchers should carefully consider whether a 
comparison group will be enrolled and strive to ensure that 
the comparison group is randomly selected from a compre-
hensive listing of the target population. 
DISCUSSION
In using electronic data, several potential limitations must be 
considered, including imprecision, potential sources of bias, 
and the generalizability of the results.
 Imprecision may arise from the study size or from the 
measurement of exposures, confounders, or outcomes. A 
variety of strategies, including detailed chart review and phy-
sician query, may be used to evaluate the validity of measure-
ments in electronic databases. Dermatologic outcomes, in 
particular, tend to be less conducive to precise measurement 
in electronic databases because few diagnoses are based on 
routinely collected data. A researcher studying hypertension, 
for example, is likely to find more standardized data than a 
researcher hoping to study changes in acne lesion counts. 
Therefore, current databases are generally more useful for 
studying the incidence or prevalence of dermatologic disease 
than for studying disease resolution or changes in disease 
severity over time. Standardization of outcome scales and/or 
photographic assessments at regular intervals offer potential 
for improvement. 
 Bias is a systematic deviation of a study’s result from a 
true value. Typically, it is introduced during the design of a 
study from flawed information or subject selection. There are 
many types of bias; two that may be particularly relevant to 
database studies include information bias and selection bias. 
Information bias occurs where there are systematic differenc-
es in the accuracy or completeness of data leading to differ-
ential misclassification of individuals regarding exposures or 
outcomes. For example, patients with a family history of mel-
1. Which of the following is not an example of an 
 analytical study? 
A. Cross-sectional study.
B. Case series study.
C. Case–control study.
D. Cohort study.
2. Which of the following is the most important 
 consideration when choosing a database for 
 clinical research? 
A. Whether the data come from an electronic 
 medical record.
B. Loss to follow-up. 
C. The research question. 
D. The generalizability of the population.
3. Which of the following is not a recommendation 
 regarding patient enrollment and follow-up in a new 
 longitudinal database (sometimes called a 
 patient registry)? 
A. Use similar procedures at all sites.
B. Use validated outcome measures whenever 
 possible.
C. Never obtain emergency contact information. 
D. Develop a patient retention plan. 
4. Which of the following is an example of information 
 bias? 
A. Patients with a family history of melanoma are 
 more likely to be recruited into a study.
B. Patients with a family history of melanoma are 
 more likely to receive skin checks and biopsies.
C. Patients with a family history of melanoma are 
 more likely to know whether they have a history 
 of atypical moles. 
D. Patients with a family history of melanoma are 
 more likely to use sunscreen. 
5. Which of the following is an example of selection 
 bias? 
A. Eczema diagnostic codes are sometimes used for 
 contact dermatitis. 
B. Eczema patients with severe disease are more 
 likely to have herpes cultures sent.
C. Eczema patients with mild disease are less likely 
 to see their providers.
D. Mothers of children with bad eczema are more 
 likely to recall infections during the perinatal 
 period.
QUESTIONS
This article has been approved for 1 hour of Category 1 CME credit. To 
take the quiz, with or without CME credit, follow the link under the “CME 
ACCREDITATION” heading.
For each question, more than one answer may be correct.
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School of Medicine is accredited by the ACCME to provide continuing medi-
cal education for physicians. To participate in the CME activity, follow the link 
provided. Physicians should only claim credit commensurate with the extent 
of their participation in the activity.
To take the online quiz, follow the link: http://continuingeducation.dcri.duke.
edu/research-techniques-made-simple-journal-based-cme-rtms
SUPPLEMENTARY MATERIAL
A PowerPoint slide presentation appropriate for journal club or other 
teaching exercises is available at http://dx.doi.org/10.1038/jid.2015.213.
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anoma may be more likely to receive skin checks and biop-
sies, making it appear that they have higher rates of atypical 
nevi. One potential way to assess the influence of some types 
of information bias is to measure the intensity of medical sur-
veillance in the different study groups and to adjust for this 
in statistical analyses. Selection bias may be introduced if 
the probability of including subjects in the study (or prob-
ability of subjects being lost to follow-up) is associated with 
exposure or outcome. For example, a study of patients fol-
lowed in clinics may overestimate the severity of a disease 
because patients with mild disease who seek medical advice 
less frequently are underrepresented. Selection bias affects 
the internal validity of a study, but it is often related to the 
external validity or generalizability of the results. 
 Generalizability refers to how representative the results 
from the study population are to the general population. 
Studies that only enroll patients from tertiary-care centers or 
that only include patients with particular demographic char-
acteristics may have limited generalizability. 
 The ideal database depends on the research question. 
Generically speaking, an ideal database might include linked 
records from inpatient and outpatient care, emergency care, 
mental-health care, all laboratory and radiological tests, and 
all prescribed and over-the-counter treatments, as well as 
alternative therapies. The population would be large enough 
to permit discovery of rare events and interactions, would be 
stable over time, and would be representative of the general 
population from which it was drawn. It would include genet-
ic, social, and physiologic information on all members, and 
there would be the ability to gather additional information, 
either from physicians or from patients themselves, to con-
firm outcomes.
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